BIOMAT Database Logo BIOMAT Database Logo

Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities. 2011

Curtis J Omiecinski, and John P Vanden Heuvel, and Gary H Perdew, and Jeffrey M Peters
Department of Veterinary and Biomedical Sciences, Center for Molecular Toxicology and Carcinogenesis, Penn State University, University Park, Pennsylvania 16802, USA. cjo10@psu.edu

To commemorate the 50th anniversary of the Society of Toxicology, this special edition article reviews the history and current scope of xenobiotic metabolism and transport, with special emphasis on the discoveries and impact of selected "xenobiotic receptors." This overall research realm has witnessed dynamic development in the past 50 years, and several of the key milestone events that mark the impressive progress in these areas of toxicological sciences are highlighted. From the initial observations regarding aspects of drug metabolism dating from the mid- to late 1800's, the area of biotransformation research witnessed seminal discoveries in the mid-1900's and onward that are remarkable in retrospect, including the discovery and characterization of the phase I monooxygenases, the cytochrome P450s. Further research uncovered many aspects of the biochemistry of xenobiotic metabolism, expanding to phase II conjugation and phase III xenobiotic transport. This led to hallmark developments involving integration of genomic technologies to elucidate the basis for interindividual differences in response to xenobiotic exposures and discovery of nuclear and soluble receptor families that selectively "sense" the chemical milieu of the mammalian cell and orchestrate compensatory changes in gene expression programming to accommodate complex xenobiotic exposures. This review will briefly summarize these developments and investigate the expanding roles of xenobiotic receptor biology in the underlying basis of toxicological response to chemical agents.

UI MeSH Term Description Entries
D008658 Inactivation, Metabolic Reduction of pharmacologic activity or toxicity of a drug or other foreign substance by a living system, usually by enzymatic action. It includes those metabolic transformations that make the substance more soluble for faster renal excretion. Detoxication, Drug, Metabolic,Drug Detoxication, Metabolic,Metabolic Detoxication, Drug,Detoxification, Drug, Metabolic,Metabolic Detoxification, Drug,Metabolic Drug Inactivation,Detoxication, Drug Metabolic,Detoxication, Metabolic Drug,Detoxification, Drug Metabolic,Drug Inactivation, Metabolic,Drug Metabolic Detoxication,Drug Metabolic Detoxification,Inactivation, Metabolic Drug,Metabolic Drug Detoxication,Metabolic Inactivation
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015262 Xenobiotics Chemical substances that are foreign to the biological system. They include naturally occurring compounds, drugs, environmental agents, carcinogens, insecticides, etc. Xenobiotic
D018160 Receptors, Cytoplasmic and Nuclear Intracellular receptors that can be found in the cytoplasm or in the nucleus. They bind to extracellular signaling molecules that migrate through or are transported across the CELL MEMBRANE. Many members of this class of receptors occur in the cytoplasm and are transported to the CELL NUCLEUS upon ligand-binding where they signal via DNA-binding and transcription regulation. Also included in this category are receptors found on INTRACELLULAR MEMBRANES that act via mechanisms similar to CELL SURFACE RECEPTORS. Cytoplasmic Receptor,Cytoplasmic and Nuclear Receptors,Cytosolic and Nuclear Receptors,Hormone Receptors, Cytoplasmic,Hormone Receptors, Nuclear,Nuclear Hormone Receptor,Nuclear Receptor,Nuclear and Cytoplasmic Receptors,Cytoplasmic Hormone Receptors,Cytoplasmic Receptors,Cytosol and Nuclear Receptors,Intracellular Membrane Receptors,Nuclear Hormone Receptors,Nuclear Receptors,Receptors, Cytoplasmic,Receptors, Cytosol and Nuclear,Receptors, Cytosolic and Nuclear,Receptors, Intracellular Membrane,Receptors, Nuclear,Receptors, Nuclear and Cytoplasmic,Hormone Receptor, Nuclear,Membrane Receptors, Intracellular,Receptor, Cytoplasmic,Receptor, Nuclear,Receptor, Nuclear Hormone,Receptors, Cytoplasmic Hormone,Receptors, Nuclear Hormone
D023281 Genomics The systematic study of the complete DNA sequences (GENOME) of organisms. Included is construction of complete genetic, physical, and transcript maps, and the analysis of this structural genomic information on a global scale such as in GENOME WIDE ASSOCIATION STUDIES. Functional Genomics,Structural Genomics,Comparative Genomics,Genomics, Comparative,Genomics, Functional,Genomics, Structural

Related Publications

Curtis J Omiecinski, and John P Vanden Heuvel, and Gary H Perdew, and Jeffrey M Peters
Regulation of xenobiotic metabolism by orphan nuclear receptors.
January 2001, Toxicologic pathology,
Curtis J Omiecinski, and John P Vanden Heuvel, and Gary H Perdew, and Jeffrey M Peters
Regulation of sulfotransferases by xenobiotic receptors.
August 2005, Current drug metabolism,
Curtis J Omiecinski, and John P Vanden Heuvel, and Gary H Perdew, and Jeffrey M Peters
Xenobiotic-activated receptors: from transcription to drug metabolism to disease.
September 2008, Chemical research in toxicology,
Curtis J Omiecinski, and John P Vanden Heuvel, and Gary H Perdew, and Jeffrey M Peters
Regulation of hepatic transporters by xenobiotic receptors.
August 2005, Current drug metabolism,
Curtis J Omiecinski, and John P Vanden Heuvel, and Gary H Perdew, and Jeffrey M Peters
The Roles of Xenobiotic Receptors: Beyond Chemical Disposition.
September 2018, Drug metabolism and disposition: the biological fate of chemicals,
Curtis J Omiecinski, and John P Vanden Heuvel, and Gary H Perdew, and Jeffrey M Peters
Regulation of drug transport by new xenobiotic receptors.
January 2001, The pharmacogenomics journal,
Curtis J Omiecinski, and John P Vanden Heuvel, and Gary H Perdew, and Jeffrey M Peters
Collection of feces for studies of xenobiotic metabolism and disposition.
January 1981, Methods in enzymology,
Curtis J Omiecinski, and John P Vanden Heuvel, and Gary H Perdew, and Jeffrey M Peters
Transporters and xenobiotic disposition.
December 2002, Toxicology,
Curtis J Omiecinski, and John P Vanden Heuvel, and Gary H Perdew, and Jeffrey M Peters
Vitamin E, nuclear receptors and xenobiotic metabolism.
March 2004, Archives of biochemistry and biophysics,
Curtis J Omiecinski, and John P Vanden Heuvel, and Gary H Perdew, and Jeffrey M Peters
Coordinate regulation of drug metabolism by xenobiotic nuclear receptors: UGTs acting together with CYPs and glucuronide transporters.
October 2004, Drug metabolism reviews,
Copied contents to your clipboard!